John Dixon

Antagonists of the Platelet P<i>_2T</i> Receptor:  A Novel Approach to Antithrombotic Therapy

Anthony H. Ingall, John Dixon, Andrew Bailey et al. · Journal of Medicinal Chemistry · 1999 · 285 citations

Antithrombotic Therapy, Novel Approach, Pharmacotherapy +17

From ATP to AZD6140: The discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis

Brian Springthorpe, A. S. Bailey, Patrick Barton et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 233 citations · Full text

Thrombosis, Platelet Aggregation Inhibitors, Biochemistry +8

The Link Between Nutritional Status and Insulin Sensitivity Is Dependent on the Adipocyte-Specific Peroxisome Proliferator–Activated Receptor-γ2 Isoform

Gema Medina‐Gómez, Sam Virtue, Christopher J. Lelliott et al. · Diabetes · 2005 · 168 citations · Full text

Nutrition, Metabolic Disorder, Insulin Signaling +17

Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozole

William R. Miller, Alexey A. Larionov, Lorna Renshaw et al. · Pharmacogenetics and Genomics · 2007 · 106 citations

Oestrogen receptor concentration in primary breast cancer and axillary node metastases

R. A. Hawkins, Robert B. Black, R. Steele et al. · Breast Cancer Research and Treatment · 1981 · 62 citations

Oestrogen Receptor Concentration, Breast Oncology, Medicine +9